RNA Methylations in Cardiovascular Diseases, Molecular Structure, Biological Functions and Regulatory Roles in

Wanwan Zhou1, Changhui Wang2, Jun Chang3

  • 1Department of Pharmacology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China.

Frontiers in Pharmacology
|September 7, 2021
PubMed

Insights

RNA methylations, including m6A, are crucial in cardiovascular diseases (CVDs). Understanding these RNA modifications offers new diagnostic and therapeutic targets for heart conditions.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiology

Background:

  • Cardiovascular diseases (CVDs) remain a leading global cause of death.
  • Current diagnostic and therapeutic strategies for CVDs require enhancement.
  • RNA modifications, particularly methylation, play vital roles in cellular processes.

Purpose of the Study:

  • To review the molecular structures and biological functions of five RNA methylations: m6A, m5C, m1a, m6am, and m7G.
  • To examine the effects of these RNA methylations on various cardiovascular diseases.
  • To highlight RNA methylation as a potential area for novel CVD biomarkers and therapies.

Main Methods:

  • Literature review focusing on the roles of RNA methylations in CVD pathogenesis.
  • Analysis of the mechanisms involving RNA methylation 'writers', 'erasers', and 'readers'.
  • Synthesis of current knowledge on m6A, m5C, m1a, m6am, and m7G in cardiovascular conditions.

Main Results:

  • RNA methylations significantly impact RNA processing, including nuclear export, translation, and splicing.
  • The m6A modification, regulated by writers, erasers, and readers, influences mRNA fate in CVDs.
  • Emerging roles of m5C, m1a, m6am, and m7G in CVDs warrant further investigation.

Conclusions:

  • RNA methylations are increasingly recognized as critical players in cardiovascular pathophysiology.
  • Further research into RNA methylation mechanisms can uncover new diagnostic markers for CVDs.
  • Targeting RNA methylation pathways presents a promising avenue for developing innovative therapeutic strategies for cardiovascular diseases.

Related Concept Videos

Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
341
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.2K
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
34.2K
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
8.0K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
7.5K
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
423